Global Point of Care (PoC) Diagnostics Market Size Estimated to Reach USD 24.70 Billion by 2028: Polaris Market Research

Global Point of Care (PoC) Diagnostics Market Size Estimated to Reach USD 24.70 Billion by 2028: Polaris Market Research
According to the research report, the global Point of Care (PoC) Diagnostics Market size & share was valued at USD 18.91 Billion in 2020 and is expected to reach USD 24.70 Billion By 2028, and will grow at a CAGR of 3.4% during the forecast period.

According to the research report, the global Point of Care (PoC) Diagnostics Market size & share was valued at USD 18.91 Billion in 2020 and is expected to reach USD 24.70 Billion By 2028, and will grow at a CAGR of 3.4% during the forecast period.

The requirement for speedy test results gained momentum, and specific testing devices became portable and easy to use. Therefore, point of care diagnostic developed once again. Today results from chemical laboratories persist as an essential element of healthcare. But, they are now accompanied by tests carried outside of the laboratory, wherever the person is. Commonly point of care diagnostics surround any tests executed at or near a patient and at the location where treatment or care is offered. Results are generally obtainable speedily so that they can be pursued without delay.

Devices for point of care diagnostics appear in various formations. They might use dipsticks like urinalysis, handheld gadgets like glucose meters, or advanced molecular analyzers to determine infectious diseases. A healthcare professional may utilize the handheld device to carry out a test at the bedside of the patient. On the other hand, the healthcare professional may gather a blood sample from the patient and carry the selection from the hallway to a satellite lab where the model is tested and processed on apparatus.

Request Sample Copy of Research Report @

Key Highlights of The Report

  • In-depth analysis of the global Point of Care (PoC) diagnostics market with prevalent market trends and subsequent assessment to explain the approaching pockets of investments in the market
  • A quantitative analysis to sanction stakeholders to leverage existing market opportunities
  • A thorough analysis of the market by product to explain diverse kinds of devices utilized to identify various diseases
  • Aggressive judgment underscores the practices of business followed by players from different geographical regions


Top Market Players Are:

  • Roche Diagnostics
  • EKF Diagnostics
  • Siemens Healthineers
  • Chembio Diagnostic Systems
  • Johnson & Johnson
  • Abbott Laboratories
  • Becton
  • Dickinson and Company
  • Danaher Corporation
  • Quidel Corporation
  • Nova Biomedical
  • PTS Diagnostics
  • Trinity Biotech
  • AccuBioTech
  • Instrumentation Laboratory Company
  • Sekisui Diagnostics


Request for Discount Price on this Report @

Important Questions Being Answered by The Market Report

  • What is the global Point of Care (PoC) diagnostics market size and growth?
  • What is the value of the market in North America?
  • What is the critical factor driving the global Point of Care (PoC) diagnostics market?
  • Who are the prominent players in the global Point of Care (PoC) diagnostics market?
  • Which region held the highest share in the market?
  • Which factors are anticipated to push the adoption of speedy testing kits?


Point of Care (PoC) Diagnostics Market: Growth Leading Factors

The growing patient population is prone to Point of Care (PoC) diagnostics at several clinics, hospitals and diagnostics centers, and so on. As tests at the patient care create swift turnaround time and assist in speedy management of disease, the element is accountable for pushing the growth of the market.

Due to growing overload in curtailing the number of patients agonized by several diseases like infectious diseases, HIV, and diabetes, pharmaceutical colossal has become concentrated on inaugurating accurate and innovative testing kits. The global market value will be boosted by thrusting adoption and higher sales. Continuous product launches by significant players will provide for the creation of higher market revenue.

Due to unreliability concerning the impact and duration of the covid-19 pandemic, the Point of Care (PoC) diagnostics industry is assessed to observe a robust upward trend in its growth rate. It was predominantly because of growth in the covid-19 testing exclusively. But there was a reduction in routine testing procedures of infectious diseases and monitoring of blood glucose. But the launch of covid-19 Point of Care (PoC) diagnostics kits by companies has elevated revenue growth.

Inquire more about this report before purchase @

(You may enquire a report quote OR available discount offers to our sales team before purchase.)

Global Point of Care (PoC) Diagnostics Market: Report Scope

Report Attribute


Market Size 2020 Value

USD 18.91 Billion

Market Outlook for 2028

USD 24.70 Billion

Expected CAGR Growth

3.4% from 2021 – 2028

Base year


Forecast period

2021 – 2028

Segments covered

By Product, By Platform, By End-Use, By Region

Key Companies

Roche Diagnostics, EKF Diagnostics, Siemens Healthineers, Chembio Diagnostic Systems, Johnson & Johnson, Abbott Laboratories, Becton, Dickinson and Company, Danaher Corporation, Quidel Corporation, Nova Biomedical, PTS Diagnostics, Trinity Biotech, AccuBioTech, Instrumentation Laboratory Company, and Sekisui Diagnostics

Regional scope

North America, Europe, Asia Pacific, Latin America, Middle East & Africa

Customization Options

Customized purchase options are available to meet your research needs.


Point of Care (PoC) Diagnostics Market: Key Segmentation

  • Insight by product, platform, end-use, and region


Based on the product, the glucose monitoring segment is anticipated to instruct the most significant share due to the growing number of Point of Care (PoC) glucose monitoring devices and the increasing existence of diabetes. Based on the platform, the micro fluids segment is anticipated to record the speediest growth rate. Technology progression and growing ingenuity by market players vouch for advancing new micro fluids dependent on Point of Care (PoC) products pushing the segment in the market. By end-use, the hospital bedside segment dominated the market due to the growing acquisition of progressive instruments and speedy investments in the private and public sector in hospital infrastructure in developing countries.

By region, North America is emerging as a dominant market because of the acquisition of advanced POC diagnostics solutions to discover several infectious diseases. Alliances and partnerships that are strategic between the important players are also factors that compel the growth of the North American region. The organizations like Bill and  Melinda Gates Foundation and Clinton Health Access Initiatives offer access to covid-19 rapid tests in middle and low-income countries. The Asia Pacific region is expected to see a dominant growth due to the growing number of market players infiltrating the untraversed economies in the Asia Pacific region. Additionally, the excessive adoption of Point of Care (PoC) diagnostics kits in countries like China and India also supports the growth of the market in the area.

Browse the full “Point of Care (PoC) Diagnostics Market Share, Size, Trends, Industry Analysis Report, By Platform (Lateral Flow Assays, Dipsticks, Microfluidics, Molecular Diagnostics, Immunoassays); By End-Use (Clinics, Hospitals, Home, Assisted Living Healthcare Facilities, Laboratory); By Product; By Regions; Segment Forecast, 2021 – 2028” Report at

The market primarily depends on the product, platform, end-use, and region

Point of Care (PoC) Diagnostics: By product

  • Glucose Testing
  • Hb1Ac Testing
  • Coagulation
  • Fertility
  • Infectious Diseases
    • HIV
    • Clostridium Difficile
    • HBV
    • Pneumonia or Streptococcus Associated Infections
    • Respiratory Syncytial Virus (RSV)
    • HPV
    • Influenza/Flu
    • HCV
    • MRSA
    • TB and Drug-Resistant TB
    • HSV
    • Others
  • Cardiac Markers
  • Thyroid Stimulating Hormone
  • Hematology
  • Primary Care Systems
  • Decentralized Clinical Chemistry
  • Feces
  • Lipid Testing
  • Cancer Marker
  • Blood Gas/Electrolytes
  • Ambulatory Chemistry
  • Drug Abuse Testing
  • Urinalysis


Point of Care (PoC) Diagnostics Market: By platform

  • Lateral Flow Assays
  • Dipsticks
  • Microfluidics
  • Molecular Diagnostics
  • Immunoassays


Point of Care (PoC) Diagnostics Market: By end-use

  • Clinics
    • Physician Office
    • Pharmacy & Retail Clinics
    • Non-practice Clinics
    • Urgent Care Clinic
  • Hospitals
  • Home
  • Assisted Living Healthcare Facilities
  • Laboratory


About Us:

Polaris Market Research is a worldwide market research and consulting organization. We give unmatched nature of offering to our customers present all around the globe across industry verticals. Polaris Market Research has expertise in giving deep-dive market insight along with market intelligence to our customers spread crosswise over various undertakings. We at Polaris are obliged to serve our different client base present over the enterprises of medicinal services, healthcare, innovation, next-gen technologies, semiconductors, chemicals, automotive, and aerospace & defense, among different ventures, present globally.

Media Contact
Company Name: Polaris Market Research and Consulting
Contact Person: Likhil
Email: Send Email
Phone: +1-9292-97-97-27
Address:30 Wall Street 8th Floor, New York City, NY 10005, United States
City: New York City
State: US
Country: United States